Rx Industry Pricing Model Must Change, Former Merck CEO Vagelos Says
Executive Summary
The pharmaceutical industry needs to rethink its approach to pricing or face dire consequences, former Merck CEO Roy Vagelos told the Pharma, Biotech & Device Colloquium in Princeton, N.J. June 9